Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk of dying from their cancer compared to similar patients who were not taking statins, according to a study published today in the journal Blood Advances.
“This is the first systematic evaluation of the association of statin use with survival outcomes in patients with CLL or SLL who have been…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply